RevitaPROST capsules for prostatitis are convenient to take and with their help you can quickly achieve the desired result and get rid of the disease. Leading urologists of our country recommend them to all their patients with the problem of inflammation of the prostate in order to quickly restore men's health and prevent relapses.
Clinical studies and experience of widespread use of the drug prove that the drug has no contraindications. It is based exclusively on natural ingredients that do not harm the body, without fragrances, dyes and chemical compounds. The product can be taken with other medications, so it does not cause side effects and does not interact with chemical elements.
The properties of the RevitaPROST composition allow you to achieve the best result, as each of its components enhances the effect of the other. This gives us the right to claim that these capsules for the treatment of prostatitis are unique and have no analogues in the world.
Urologists advise all men with prostatitis problems to take the drug depending on the indications and for prevention. The disease is usually accompanied by the following symptoms:
Treatment should begin immediately as soon as signs of the disease are detected. This helps prevent serious complications such as tumors, infertility, vesiculitis, impotence, pelvic pain and urinary incontinence.
RevitaPROST has no serious contraindications to use. An exception may be an individual intolerance to the ingredients contained in this product. There is no age restriction, but you should strictly follow the manufacturer's recommendations.
To achieve results, you need to know how to use RevitaPROST capsules manufactured in Spain to eliminate prostate inflammation. Each package of the drug contains detailed instructions with a description. The daily dose is two capsules, taken orally one at a time, 10-12 hours apart. It is most convenient to take the first dose half an hour before breakfast and the second dose 10 minutes before dinner. Drink with clean, still water. The duration of therapy depends on the severity of the disease; the average course is usually two months.
